Pharma & Healthcare

Global Synthesis Polypeptide Drugs Market Insights, Forecast to 2030

Polypeptide synthesis is the biological production of peptides, which are organic compounds in which multiple amino acids are linked via peptide bonds.
The global Synthesis Polypeptide Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Synthesis Polypeptide Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Synthesis Polypeptide Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Synthesis Polypeptide Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Synthesis Polypeptide Drugs include Novartis, Thermo Fisher Scientific, Merck Millipore, Ferring Pharmaceuticals, AstraZeneca, HYBIO Pharmaceutical, Hainan Zhonghe Pharmaceutical, PolyPeptide and Abzena, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Synthesis Polypeptide Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Synthesis Polypeptide Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Synthesis Polypeptide Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Synthesis Polypeptide Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Synthesis Polypeptide Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Synthesis Polypeptide Drugs sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Merck Millipore
Ferring Pharmaceuticals
AstraZeneca
HYBIO Pharmaceutical
Hainan Zhonghe Pharmaceutical
PolyPeptide
Abzena
CPC Scientific
Segment by Type
Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug (hCG)
Urinary System Drug (Diabetes Insipidus)
Other
Segment by Application
Gene Delivery
Drug Delivery
Bio-Imaging
Tissue Engineering
Antimicrobials
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Synthesis Polypeptide Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Synthesis Polypeptide Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Synthesis Polypeptide Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Synthesis Polypeptide Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Synthesis Polypeptide Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Immunity Regulating Medicine (Allergy Infection and Immune)
1.2.3 Digestive System Drugs (Gastrointestinal Type)
1.2.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
1.2.5 Gynecologic or Obstetric Drug
1.2.6 Tumor Drug (hCG)
1.2.7 Urinary System Drug (Diabetes Insipidus)
1.2.8 Other
1.3 Market by Application
1.3.1 Global Synthesis Polypeptide Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Gene Delivery
1.3.3 Drug Delivery
1.3.4 Bio-Imaging
1.3.5 Tissue Engineering
1.3.6 Antimicrobials
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Synthesis Polypeptide Drugs Sales Estimates and Forecasts 2019-2030
2.2 Global Synthesis Polypeptide Drugs Revenue by Region
2.2.1 Global Synthesis Polypeptide Drugs Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Synthesis Polypeptide Drugs Revenue by Region (2019-2024)
2.2.3 Global Synthesis Polypeptide Drugs Revenue by Region (2025-2030)
2.2.4 Global Synthesis Polypeptide Drugs Revenue Market Share by Region (2019-2030)
2.3 Global Synthesis Polypeptide Drugs Sales Estimates and Forecasts 2019-2030
2.4 Global Synthesis Polypeptide Drugs Sales by Region
2.4.1 Global Synthesis Polypeptide Drugs Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Synthesis Polypeptide Drugs Sales by Region (2019-2024)
2.4.3 Global Synthesis Polypeptide Drugs Sales by Region (2025-2030)
2.4.4 Global Synthesis Polypeptide Drugs Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Synthesis Polypeptide Drugs Sales by Manufacturers
3.1.1 Global Synthesis Polypeptide Drugs Sales by Manufacturers (2019-2024)
3.1.2 Global Synthesis Polypeptide Drugs Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Synthesis Polypeptide Drugs in 2023
3.2 Global Synthesis Polypeptide Drugs Revenue by Manufacturers
3.2.1 Global Synthesis Polypeptide Drugs Revenue by Manufacturers (2019-2024)
3.2.2 Global Synthesis Polypeptide Drugs Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Synthesis Polypeptide Drugs Revenue in 2023
3.3 Global Key Players of Synthesis Polypeptide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Synthesis Polypeptide Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Synthesis Polypeptide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Synthesis Polypeptide Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Synthesis Polypeptide Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Synthesis Polypeptide Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Synthesis Polypeptide Drugs Sales by Type
4.1.1 Global Synthesis Polypeptide Drugs Historical Sales by Type (2019-2024)
4.1.2 Global Synthesis Polypeptide Drugs Forecasted Sales by Type (2025-2030)
4.1.3 Global Synthesis Polypeptide Drugs Sales Market Share by Type (2019-2030)
4.2 Global Synthesis Polypeptide Drugs Revenue by Type
4.2.1 Global Synthesis Polypeptide Drugs Historical Revenue by Type (2019-2024)
4.2.2 Global Synthesis Polypeptide Drugs Forecasted Revenue by Type (2025-2030)
4.2.3 Global Synthesis Polypeptide Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Synthesis Polypeptide Drugs Price by Type
4.3.1 Global Synthesis Polypeptide Drugs Price by Type (2019-2024)
4.3.2 Global Synthesis Polypeptide Drugs Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Synthesis Polypeptide Drugs Sales by Application
5.1.1 Global Synthesis Polypeptide Drugs Historical Sales by Application (2019-2024)
5.1.2 Global Synthesis Polypeptide Drugs Forecasted Sales by Application (2025-2030)
5.1.3 Global Synthesis Polypeptide Drugs Sales Market Share by Application (2019-2030)
5.2 Global Synthesis Polypeptide Drugs Revenue by Application
5.2.1 Global Synthesis Polypeptide Drugs Historical Revenue by Application (2019-2024)
5.2.2 Global Synthesis Polypeptide Drugs Forecasted Revenue by Application (2025-2030)
5.2.3 Global Synthesis Polypeptide Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Synthesis Polypeptide Drugs Price by Application
5.3.1 Global Synthesis Polypeptide Drugs Price by Application (2019-2024)
5.3.2 Global Synthesis Polypeptide Drugs Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Synthesis Polypeptide Drugs Market Size by Type
6.1.1 US & Canada Synthesis Polypeptide Drugs Sales by Type (2019-2030)
6.1.2 US & Canada Synthesis Polypeptide Drugs Revenue by Type (2019-2030)
6.2 US & Canada Synthesis Polypeptide Drugs Market Size by Application
6.2.1 US & Canada Synthesis Polypeptide Drugs Sales by Application (2019-2030)
6.2.2 US & Canada Synthesis Polypeptide Drugs Revenue by Application (2019-2030)
6.3 US & Canada Synthesis Polypeptide Drugs Market Size by Country
6.3.1 US & Canada Synthesis Polypeptide Drugs Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Synthesis Polypeptide Drugs Sales by Country (2019-2030)
6.3.3 US & Canada Synthesis Polypeptide Drugs Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Synthesis Polypeptide Drugs Market Size by Type
7.1.1 Europe Synthesis Polypeptide Drugs Sales by Type (2019-2030)
7.1.2 Europe Synthesis Polypeptide Drugs Revenue by Type (2019-2030)
7.2 Europe Synthesis Polypeptide Drugs Market Size by Application
7.2.1 Europe Synthesis Polypeptide Drugs Sales by Application (2019-2030)
7.2.2 Europe Synthesis Polypeptide Drugs Revenue by Application (2019-2030)
7.3 Europe Synthesis Polypeptide Drugs Market Size by Country
7.3.1 Europe Synthesis Polypeptide Drugs Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Synthesis Polypeptide Drugs Sales by Country (2019-2030)
7.3.3 Europe Synthesis Polypeptide Drugs Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Synthesis Polypeptide Drugs Market Size
8.1.1 China Synthesis Polypeptide Drugs Sales (2019-2030)
8.1.2 China Synthesis Polypeptide Drugs Revenue (2019-2030)
8.2 China Synthesis Polypeptide Drugs Market Size by Application
8.2.1 China Synthesis Polypeptide Drugs Sales by Application (2019-2030)
8.2.2 China Synthesis Polypeptide Drugs Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Synthesis Polypeptide Drugs Market Size by Type
9.1.1 Asia Synthesis Polypeptide Drugs Sales by Type (2019-2030)
9.1.2 Asia Synthesis Polypeptide Drugs Revenue by Type (2019-2030)
9.2 Asia Synthesis Polypeptide Drugs Market Size by Application
9.2.1 Asia Synthesis Polypeptide Drugs Sales by Application (2019-2030)
9.2.2 Asia Synthesis Polypeptide Drugs Revenue by Application (2019-2030)
9.3 Asia Synthesis Polypeptide Drugs Sales by Region
9.3.1 Asia Synthesis Polypeptide Drugs Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Synthesis Polypeptide Drugs Revenue by Region (2019-2030)
9.3.3 Asia Synthesis Polypeptide Drugs Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Synthesis Polypeptide Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Synthesis Polypeptide Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Synthesis Polypeptide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Novartis Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Overview
11.2.3 Thermo Fisher Scientific Synthesis Polypeptide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Thermo Fisher Scientific Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Merck Millipore
11.3.1 Merck Millipore Company Information
11.3.2 Merck Millipore Overview
11.3.3 Merck Millipore Synthesis Polypeptide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Merck Millipore Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Millipore Recent Developments
11.4 Ferring Pharmaceuticals
11.4.1 Ferring Pharmaceuticals Company Information
11.4.2 Ferring Pharmaceuticals Overview
11.4.3 Ferring Pharmaceuticals Synthesis Polypeptide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Ferring Pharmaceuticals Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ferring Pharmaceuticals Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Synthesis Polypeptide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 AstraZeneca Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 HYBIO Pharmaceutical
11.6.1 HYBIO Pharmaceutical Company Information
11.6.2 HYBIO Pharmaceutical Overview
11.6.3 HYBIO Pharmaceutical Synthesis Polypeptide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 HYBIO Pharmaceutical Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 HYBIO Pharmaceutical Recent Developments
11.7 Hainan Zhonghe Pharmaceutical
11.7.1 Hainan Zhonghe Pharmaceutical Company Information
11.7.2 Hainan Zhonghe Pharmaceutical Overview
11.7.3 Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hainan Zhonghe Pharmaceutical Recent Developments
11.8 PolyPeptide
11.8.1 PolyPeptide Company Information
11.8.2 PolyPeptide Overview
11.8.3 PolyPeptide Synthesis Polypeptide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 PolyPeptide Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 PolyPeptide Recent Developments
11.9 Abzena
11.9.1 Abzena Company Information
11.9.2 Abzena Overview
11.9.3 Abzena Synthesis Polypeptide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Abzena Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Abzena Recent Developments
11.10 CPC Scientific
11.10.1 CPC Scientific Company Information
11.10.2 CPC Scientific Overview
11.10.3 CPC Scientific Synthesis Polypeptide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 CPC Scientific Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CPC Scientific Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Synthesis Polypeptide Drugs Industry Chain Analysis
12.2 Synthesis Polypeptide Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Synthesis Polypeptide Drugs Production Mode & Process
12.4 Synthesis Polypeptide Drugs Sales and Marketing
12.4.1 Synthesis Polypeptide Drugs Sales Channels
12.4.2 Synthesis Polypeptide Drugs Distributors
12.5 Synthesis Polypeptide Drugs Customers
13 Market Dynamics
13.1 Synthesis Polypeptide Drugs Industry Trends
13.2 Synthesis Polypeptide Drugs Market Drivers
13.3 Synthesis Polypeptide Drugs Market Challenges
13.4 Synthesis Polypeptide Drugs Market Restraints
14 Key Findings in The Global Synthesis Polypeptide Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Synthesis Polypeptide Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Immunity Regulating Medicine (Allergy Infection and Immune)
Table 3. Major Manufacturers of Digestive System Drugs (Gastrointestinal Type)
Table 4. Major Manufacturers of Bone and Connective Tissue Types (Thyroid hormones Drug)
Table 5. Major Manufacturers of Gynecologic or Obstetric Drug
Table 6. Major Manufacturers of Tumor Drug (hCG)
Table 7. Major Manufacturers of Urinary System Drug (Diabetes Insipidus)
Table 8. Major Manufacturers of Other
Table 9. Global Synthesis Polypeptide Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 10. Global Synthesis Polypeptide Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Synthesis Polypeptide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 12. Global Synthesis Polypeptide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 13. Global Synthesis Polypeptide Drugs Revenue Market Share by Region (2019-2024)
Table 14. Global Synthesis Polypeptide Drugs Revenue Market Share by Region (2025-2030)
Table 15. Global Synthesis Polypeptide Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Synthesis Polypeptide Drugs Sales by Region (2019-2024) & (MT)
Table 17. Global Synthesis Polypeptide Drugs Sales by Region (2025-2030) & (MT)
Table 18. Global Synthesis Polypeptide Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Synthesis Polypeptide Drugs Sales Market Share by Region (2025-2030)
Table 20. Global Synthesis Polypeptide Drugs Sales by Manufacturers (2019-2024) & (MT)
Table 21. Global Synthesis Polypeptide Drugs Sales Share by Manufacturers (2019-2024)
Table 22. Global Synthesis Polypeptide Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 23. Global Synthesis Polypeptide Drugs Revenue Share by Manufacturers (2019-2024)
Table 24. Global Key Players of Synthesis Polypeptide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 25. Synthesis Polypeptide Drugs Price by Manufacturers 2019-2024 (USD/Kg)
Table 26. Global Synthesis Polypeptide Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Synthesis Polypeptide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthesis Polypeptide Drugs as of 2023)
Table 28. Global Key Manufacturers of Synthesis Polypeptide Drugs, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Synthesis Polypeptide Drugs, Product Offered and Application
Table 30. Global Key Manufacturers of Synthesis Polypeptide Drugs, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Synthesis Polypeptide Drugs Sales by Type (2019-2024) & (MT)
Table 33. Global Synthesis Polypeptide Drugs Sales by Type (2025-2030) & (MT)
Table 34. Global Synthesis Polypeptide Drugs Sales Share by Type (2019-2024)
Table 35. Global Synthesis Polypeptide Drugs Sales Share by Type (2025-2030)
Table 36. Global Synthesis Polypeptide Drugs Revenue by Type (2019-2024) & (US$ Million)
Table 37. Global Synthesis Polypeptide Drugs Revenue by Type (2025-2030) & (US$ Million)
Table 38. Global Synthesis Polypeptide Drugs Revenue Share by Type (2019-2024)
Table 39. Global Synthesis Polypeptide Drugs Revenue Share by Type (2025-2030)
Table 40. Synthesis Polypeptide Drugs Price by Type (2019-2024) & (USD/Kg)
Table 41. Global Synthesis Polypeptide Drugs Price Forecast by Type (2025-2030) & (USD/Kg)
Table 42. Global Synthesis Polypeptide Drugs Sales by Application (2019-2024) & (MT)
Table 43. Global Synthesis Polypeptide Drugs Sales by Application (2025-2030) & (MT)
Table 44. Global Synthesis Polypeptide Drugs Sales Share by Application (2019-2024)
Table 45. Global Synthesis Polypeptide Drugs Sales Share by Application (2025-2030)
Table 46. Global Synthesis Polypeptide Drugs Revenue by Application (2019-2024) & (US$ Million)
Table 47. Global Synthesis Polypeptide Drugs Revenue by Application (2025-2030) & (US$ Million)
Table 48. Global Synthesis Polypeptide Drugs Revenue Share by Application (2019-2024)
Table 49. Global Synthesis Polypeptide Drugs Revenue Share by Application (2025-2030)
Table 50. Synthesis Polypeptide Drugs Price by Application (2019-2024) & (USD/Kg)
Table 51. Global Synthesis Polypeptide Drugs Price Forecast by Application (2025-2030) & (USD/Kg)
Table 52. US & Canada Synthesis Polypeptide Drugs Sales by Type (2019-2024) & (MT)
Table 53. US & Canada Synthesis Polypeptide Drugs Sales by Type (2025-2030) & (MT)
Table 54. US & Canada Synthesis Polypeptide Drugs Revenue by Type (2019-2024) & (US$ Million)
Table 55. US & Canada Synthesis Polypeptide Drugs Revenue by Type (2025-2030) & (US$ Million)
Table 56. US & Canada Synthesis Polypeptide Drugs Sales by Application (2019-2024) & (MT)
Table 57. US & Canada Synthesis Polypeptide Drugs Sales by Application (2025-2030) & (MT)
Table 58. US & Canada Synthesis Polypeptide Drugs Revenue by Application (2019-2024) & (US$ Million)
Table 59. US & Canada Synthesis Polypeptide Drugs Revenue by Application (2025-2030) & (US$ Million)
Table 60. US & Canada Synthesis Polypeptide Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 61. US & Canada Synthesis Polypeptide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 62. US & Canada Synthesis Polypeptide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 63. US & Canada Synthesis Polypeptide Drugs Sales by Country (2019-2024) & (MT)
Table 64. US & Canada Synthesis Polypeptide Drugs Sales by Country (2025-2030) & (MT)
Table 65. Europe Synthesis Polypeptide Drugs Sales by Type (2019-2024) & (MT)
Table 66. Europe Synthesis Polypeptide Drugs Sales by Type (2025-2030) & (MT)
Table 67. Europe Synthesis Polypeptide Drugs Revenue by Type (2019-2024) & (US$ Million)
Table 68. Europe Synthesis Polypeptide Drugs Revenue by Type (2025-2030) & (US$ Million)
Table 69. Europe Synthesis Polypeptide Drugs Sales by Application (2019-2024) & (MT)
Table 70. Europe Synthesis Polypeptide Drugs Sales by Application (2025-2030) & (MT)
Table 71. Europe Synthesis Polypeptide Drugs Revenue by Application (2019-2024) & (US$ Million)
Table 72. Europe Synthesis Polypeptide Drugs Revenue by Application (2025-2030) & (US$ Million)
Table 73. Europe Synthesis Polypeptide Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 74. Europe Synthesis Polypeptide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 75. Europe Synthesis Polypeptide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 76. Europe Synthesis Polypeptide Drugs Sales by Country (2019-2024) & (MT)
Table 77. Europe Synthesis Polypeptide Drugs Sales by Country (2025-2030) & (MT)
Table 78. China Synthesis Polypeptide Drugs Sales by Type (2019-2024) & (MT)
Table 79. China Synthesis Polypeptide Drugs Sales by Type (2025-2030) & (MT)
Table 80. China Synthesis Polypeptide Drugs Revenue by Type (2019-2024) & (US$ Million)
Table 81. China Synthesis Polypeptide Drugs Revenue by Type (2025-2030) & (US$ Million)
Table 82. China Synthesis Polypeptide Drugs Sales by Application (2019-2024) & (MT)
Table 83. China Synthesis Polypeptide Drugs Sales by Application (2025-2030) & (MT)
Table 84. China Synthesis Polypeptide Drugs Revenue by Application (2019-2024) & (US$ Million)
Table 85. China Synthesis Polypeptide Drugs Revenue by Application (2025-2030) & (US$ Million)
Table 86. Asia Synthesis Polypeptide Drugs Sales by Type (2019-2024) & (MT)
Table 87. Asia Synthesis Polypeptide Drugs Sales by Type (2025-2030) & (MT)
Table 88. Asia Synthesis Polypeptide Drugs Revenue by Type (2019-2024) & (US$ Million)
Table 89. Asia Synthesis Polypeptide Drugs Revenue by Type (2025-2030) & (US$ Million)
Table 90. Asia Synthesis Polypeptide Drugs Sales by Application (2019-2024) & (MT)
Table 91. Asia Synthesis Polypeptide Drugs Sales by Application (2025-2030) & (MT)
Table 92. Asia Synthesis Polypeptide Drugs Revenue by Application (2019-2024) & (US$ Million)
Table 93. Asia Synthesis Polypeptide Drugs Revenue by Application (2025-2030) & (US$ Million)
Table 94. Asia Synthesis Polypeptide Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 95. Asia Synthesis Polypeptide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 96. Asia Synthesis Polypeptide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 97. Asia Synthesis Polypeptide Drugs Sales by Region (2019-2024) & (MT)
Table 98. Asia Synthesis Polypeptide Drugs Sales by Region (2025-2030) & (MT)
Table 99. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales by Type (2019-2024) & (MT)
Table 100. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales by Type (2025-2030) & (MT)
Table 101. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue by Type (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue by Type (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales by Application (2019-2024) & (MT)
Table 104. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales by Application (2025-2030) & (MT)
Table 105. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue by Application (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue by Application (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 108. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 110. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales by Country (2019-2024) & (MT)
Table 111. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales by Country (2025-2030) & (MT)
Table 112. Novartis Company Information
Table 113. Novartis Description and Major Businesses
Table 114. Novartis Synthesis Polypeptide Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 115. Novartis Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Novartis Recent Developments
Table 117. Thermo Fisher Scientific Company Information
Table 118. Thermo Fisher Scientific Description and Major Businesses
Table 119. Thermo Fisher Scientific Synthesis Polypeptide Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 120. Thermo Fisher Scientific Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Thermo Fisher Scientific Recent Developments
Table 122. Merck Millipore Company Information
Table 123. Merck Millipore Description and Major Businesses
Table 124. Merck Millipore Synthesis Polypeptide Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 125. Merck Millipore Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Merck Millipore Recent Developments
Table 127. Ferring Pharmaceuticals Company Information
Table 128. Ferring Pharmaceuticals Description and Major Businesses
Table 129. Ferring Pharmaceuticals Synthesis Polypeptide Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 130. Ferring Pharmaceuticals Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Ferring Pharmaceuticals Recent Developments
Table 132. AstraZeneca Company Information
Table 133. AstraZeneca Description and Major Businesses
Table 134. AstraZeneca Synthesis Polypeptide Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 135. AstraZeneca Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. AstraZeneca Recent Developments
Table 137. HYBIO Pharmaceutical Company Information
Table 138. HYBIO Pharmaceutical Description and Major Businesses
Table 139. HYBIO Pharmaceutical Synthesis Polypeptide Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 140. HYBIO Pharmaceutical Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. HYBIO Pharmaceutical Recent Developments
Table 142. Hainan Zhonghe Pharmaceutical Company Information
Table 143. Hainan Zhonghe Pharmaceutical Description and Major Businesses
Table 144. Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 145. Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Hainan Zhonghe Pharmaceutical Recent Developments
Table 147. PolyPeptide Company Information
Table 148. PolyPeptide Description and Major Businesses
Table 149. PolyPeptide Synthesis Polypeptide Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 150. PolyPeptide Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. PolyPeptide Recent Developments
Table 152. Abzena Company Information
Table 153. Abzena Description and Major Businesses
Table 154. Abzena Synthesis Polypeptide Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 155. Abzena Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Abzena Recent Developments
Table 157. CPC Scientific Company Information
Table 158. CPC Scientific Description and Major Businesses
Table 159. CPC Scientific Synthesis Polypeptide Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 160. CPC Scientific Synthesis Polypeptide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. CPC Scientific Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Synthesis Polypeptide Drugs Distributors List
Table 165. Synthesis Polypeptide Drugs Customers List
Table 166. Synthesis Polypeptide Drugs Market Trends
Table 167. Synthesis Polypeptide Drugs Market Drivers
Table 168. Synthesis Polypeptide Drugs Market Challenges
Table 169. Synthesis Polypeptide Drugs Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Synthesis Polypeptide Drugs Product Picture
Figure 2. Global Synthesis Polypeptide Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Synthesis Polypeptide Drugs Market Share by Type in 2023 & 2030
Figure 4. Immunity Regulating Medicine (Allergy Infection and Immune) Product Picture
Figure 5. Digestive System Drugs (Gastrointestinal Type) Product Picture
Figure 6. Bone and Connective Tissue Types (Thyroid hormones Drug) Product Picture
Figure 7. Gynecologic or Obstetric Drug Product Picture
Figure 8. Tumor Drug (hCG) Product Picture
Figure 9. Urinary System Drug (Diabetes Insipidus) Product Picture
Figure 10. Other Product Picture
Figure 11. Global Synthesis Polypeptide Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 12. Global Synthesis Polypeptide Drugs Market Share by Application in 2023 & 2030
Figure 13. Gene Delivery
Figure 14. Drug Delivery
Figure 15. Bio-Imaging
Figure 16. Tissue Engineering
Figure 17. Antimicrobials
Figure 18. Other
Figure 19. Synthesis Polypeptide Drugs Report Years Considered
Figure 20. Global Synthesis Polypeptide Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 21. Global Synthesis Polypeptide Drugs Revenue 2019-2030 (US$ Million)
Figure 22. Global Synthesis Polypeptide Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 23. Global Synthesis Polypeptide Drugs Revenue Market Share by Region (2019-2030)
Figure 24. Global Synthesis Polypeptide Drugs Sales 2019-2030 ((MT)
Figure 25. Global Synthesis Polypeptide Drugs Sales Market Share by Region (2019-2030)
Figure 26. US & Canada Synthesis Polypeptide Drugs Sales YoY (2019-2030) & (MT)
Figure 27. US & Canada Synthesis Polypeptide Drugs Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Europe Synthesis Polypeptide Drugs Sales YoY (2019-2030) & (MT)
Figure 29. Europe Synthesis Polypeptide Drugs Revenue YoY (2019-2030) & (US$ Million)
Figure 30. China Synthesis Polypeptide Drugs Sales YoY (2019-2030) & (MT)
Figure 31. China Synthesis Polypeptide Drugs Revenue YoY (2019-2030) & (US$ Million)
Figure 32. Asia (excluding China) Synthesis Polypeptide Drugs Sales YoY (2019-2030) & (MT)
Figure 33. Asia (excluding China) Synthesis Polypeptide Drugs Revenue YoY (2019-2030) & (US$ Million)
Figure 34. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales YoY (2019-2030) & (MT)
Figure 35. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue YoY (2019-2030) & (US$ Million)
Figure 36. The Synthesis Polypeptide Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 37. The Top 5 and 10 Largest Manufacturers of Synthesis Polypeptide Drugs in the World: Market Share by Synthesis Polypeptide Drugs Revenue in 2023
Figure 38. Global Synthesis Polypeptide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 39. Global Synthesis Polypeptide Drugs Sales Market Share by Type (2019-2030)
Figure 40. Global Synthesis Polypeptide Drugs Revenue Market Share by Type (2019-2030)
Figure 41. Global Synthesis Polypeptide Drugs Sales Market Share by Application (2019-2030)
Figure 42. Global Synthesis Polypeptide Drugs Revenue Market Share by Application (2019-2030)
Figure 43. US & Canada Synthesis Polypeptide Drugs Sales Market Share by Type (2019-2030)
Figure 44. US & Canada Synthesis Polypeptide Drugs Revenue Market Share by Type (2019-2030)
Figure 45. US & Canada Synthesis Polypeptide Drugs Sales Market Share by Application (2019-2030)
Figure 46. US & Canada Synthesis Polypeptide Drugs Revenue Market Share by Application (2019-2030)
Figure 47. US & Canada Synthesis Polypeptide Drugs Revenue Share by Country (2019-2030)
Figure 48. US & Canada Synthesis Polypeptide Drugs Sales Share by Country (2019-2030)
Figure 49. U.S. Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 50. Canada Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 51. Europe Synthesis Polypeptide Drugs Sales Market Share by Type (2019-2030)
Figure 52. Europe Synthesis Polypeptide Drugs Revenue Market Share by Type (2019-2030)
Figure 53. Europe Synthesis Polypeptide Drugs Sales Market Share by Application (2019-2030)
Figure 54. Europe Synthesis Polypeptide Drugs Revenue Market Share by Application (2019-2030)
Figure 55. Europe Synthesis Polypeptide Drugs Revenue Share by Country (2019-2030)
Figure 56. Europe Synthesis Polypeptide Drugs Sales Share by Country (2019-2030)
Figure 57. Germany Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 58. France Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 59. U.K. Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 60. Italy Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 61. Russia Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 62. China Synthesis Polypeptide Drugs Sales Market Share by Type (2019-2030)
Figure 63. China Synthesis Polypeptide Drugs Revenue Market Share by Type (2019-2030)
Figure 64. China Synthesis Polypeptide Drugs Sales Market Share by Application (2019-2030)
Figure 65. China Synthesis Polypeptide Drugs Revenue Market Share by Application (2019-2030)
Figure 66. Asia Synthesis Polypeptide Drugs Sales Market Share by Type (2019-2030)
Figure 67. Asia Synthesis Polypeptide Drugs Revenue Market Share by Type (2019-2030)
Figure 68. Asia Synthesis Polypeptide Drugs Sales Market Share by Application (2019-2030)
Figure 69. Asia Synthesis Polypeptide Drugs Revenue Market Share by Application (2019-2030)
Figure 70. Asia Synthesis Polypeptide Drugs Revenue Share by Region (2019-2030)
Figure 71. Asia Synthesis Polypeptide Drugs Sales Share by Region (2019-2030)
Figure 72. Japan Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 73. South Korea Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 74. China Taiwan Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 75. Southeast Asia Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 76. India Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales Market Share by Type (2019-2030)
Figure 78. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue Market Share by Type (2019-2030)
Figure 79. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales Market Share by Application (2019-2030)
Figure 80. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue Market Share by Application (2019-2030)
Figure 81. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Revenue Share by Country (2019-2030)
Figure 82. Middle East, Africa and Latin America Synthesis Polypeptide Drugs Sales Share by Country (2019-2030)
Figure 83. Brazil Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 84. Mexico Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 85. Turkey Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 86. Israel Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 87. GCC Countries Synthesis Polypeptide Drugs Revenue (2019-2030) & (US$ Million)
Figure 88. Synthesis Polypeptide Drugs Value Chain
Figure 89. Synthesis Polypeptide Drugs Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies